Taiwan

PRODUCT NOTIFICATION SUMMARY

BD recently initiated a voluntary product notification (February 22, 2017) for a subset of Research Use Only (RUO) single vial reagents with fluorophores. This notification was initiated after observing sporadic performance and vial-to-vial variability during routine internal testing as well as through complaint investigations. (Refer to formats part of product notification in Table I)

BD has completed a thorough investigation and evaluation of product inventory, and based on those outcomes, the product notification is being expanded to include additional lots of RUO single vial reagents with fluorophores. (Refer to additional product formats in Table II)

Investigation and Root Cause

A comprehensive investigation was initiated to identify root cause and evaluate product inventory and distribution. As a result of this investigation, BD has confirmed that a prolonged exposure to high intensity broad spectrum LED lighting was the root cause that has resulted in sporadic performance and vial-to-vial variation attributable to light induced degradation in certain lots of single vial reagents. This exposure occurred after a warehouse relocation in May 2016 where LED lighting had been installed to enhance employee working conditions. Product degradation from prolonged light exposure has the potential to result in reduced signal intensity that may cause changes in cell staining patterns, lower quantitative values for positive populations or no signal. In the case of tandem dyes, it may also result in changes to the values in the fluorescence spectral overlap matrix for the reagent.

Correction

Upon identification of the impact this lighting had on the RUO single vial reagents, BD promptly took steps to modify the lighting conditions to be equivalent to the previous warehouse. All testing to date has confirmed that our correction has been effective. Additional corrective actions are under evaluation to prevent recurrence of this situation in the future.

Recommended Customer Actions

If you have purchased product lots that are part of the product notification which can be verified on the Product Lookup, we recommend you take the following actions:

  1. Discard any remaining inventory from the affected product list and request replacement, or
  2. Inspect your remaining inventory for affected products and, until replacement products are available, conduct QC testing using biological cells per your standard protocol on each vial to confirm that the reagent meets your performance expectations, and
  3. Review any data generated by your research that utilized reagents from the affected product list.

BD is diligently working to replenish the supply chain with newly manufactured product. Therefore, many SKUs are available to ship upon receipt of your replacement order. Other SKUs will ship as soon as they are available.

Table I - Product formats part of the product notification in February 2017

Product FormatBrand(s)
Alexa Fluor® 700BD Pharmingen™
BD Phosflow™
APC-Cy™7BD Pharmingen™
APC-H7BD Pharmingen™
APC-R700BD Horizon™
BUV661BD Horizon™
BV605BD Horizon™
Product FormatBrand(s)
BV650BD Horizon™
BV711BD Horizon™
BV786BD Horizon™
PE-CF594BD Horizon™
PE-Cy™5BD Pharmingen™

Table II - Product formats part of the product notification in April 2017

Product FormatBrand(s)
Alexa Fluor® 488BD Pharmingen™
BD Phosflow™
Alexa Fluor® 555BD Pharmingen™
Alexa Fluor® 647BD Pharmingen™
BD Phosflow™
APCBD Pharmingen™
BD Phosflow™
APC-H7BD Pharmingen™
BD Phosflow™
APC-R700BD Horizon™
BUV661BD Horizon™
BV510BD Horizon™
BD Phosflow™
BV650BD Horizon™
Product FormatBrand(s)
BV711BD Horizon™
BV750BD Horizon™
BV786BD Horizon™
Cy™5BD Pharmingen™
Cy™5.5BD Pharmingen™
PEBD Pharmigen™
BD Phosflow™
BD™ Cytometric Bead Array (CBA)
BD™ DimerX
PE-CF594BD Horizon™
BD Phosflow™
PE-Cy™7BD Pharmingen™
BD Phosflow™
PerCP-Cy™5.5BD Pharmingen™
BD Phosflow™